SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending due to its strategic shift towards quantum computing with potential applications in energy-efficient blockchain and cryptocurrency, drawing attention from investors. The community is actively discussing the implications of their laser-based processing unit (LPU) technology and its potential to disrupt the crypto and AI industries. Traders are also watching for news and potential partnerships related to its low float and threshold list status.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to increased interest in the quantum computing sector, fueled by new deals and government initiatives that have sparked a rally. The community is actively discussing the stock's potential and comparing it to others in the sector like IONQ and QBTS. Some traders point to the company's high valuation relative to revenue, while others remain bullish, citing long-term growth potential and recent contracts.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc is trending due to its strategic partnership with Perplexity AI, aimed at enhancing content discovery and offering a bundled premium subscription. Community discussions highlight the potential integration of AI with crypto, the involvement of key investors like Jeff Bezos, and the possibility of a short squeeze given high short interest. Some investors speculate on the impact of Tether's involvement and the potential for Rumble to gain traction in the AI space.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending due to a Jefferies downgrade, citing overly optimistic iPhone expectations, which has sparked debate among investors about its validity and impact. While some community members view the downgrade as an opportunity to buy, others express concern about Apple's valuation and potential risks related to tariffs. Broader discussions involve Apple's AI strategy, competition in the wearables market, and potential government shutdown impacts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is trending as part of a broader surge in quantum computing stocks, driven by increasing interest and speculation around government contracts and potential big tech partnerships. Community discussions revolve around the company's valuation, short squeeze potential, and its competitive position relative to other quantum firms like RGTI and IONQ. Some investors express concerns about a potential bubble, while others highlight D-Wave's technological advantages and growing real-world applications.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending as it navigates a significant private placement, leading to community discussions around dilution and future growth prospects. While some traders express concerns about the offering's impact, others view it as a strategic move to fund expansion and acquisitions in the burgeoning quantum computing sector, noting the potential for government contracts to boost the stock.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines is trending after securing an $800,000 order for drone components from Red Cat, fueling discussions about drone dominance and the company's growth potential. While some community members question if the order size justifies the stock's reaction, others see it as a sign of more substantial contracts to come, especially with increasing government and defense sector interest in drone technology. The community is also closely watching for further developments and partnerships within the drone sector.

Astrotech Corp. engages in the mass spectrometry company that launches, manages and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. Its business units include 1st Detect, BreathTech, and AgLab. The company was founded in 1984 and is headquartered in Austin, TX.

Astrotech Corp

ASTC is experiencing high volatility and significant volume, leading to a surge in price. The community is actively discussing profit-taking strategies and potential breakout levels. The stock's momentum and low float are key factors driving the current interest.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as community members discuss Needham initiating coverage with a buy rating and a price target of $17, coupled with an $800,000 order for drone components from Unusual Machines (UMAC). Bullish sentiment is fueled by the belief that RCAT's investment thesis is being validated within the unmanned aerial systems sector, anticipating further demand for defense-grade drones. The community speculates on potential catalysts, including government contracts and the company's position in the exploding drone market.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to anticipation surrounding multiple data presentations at an upcoming conference, sparking optimism within the community. Investors are discussing the potential impact of these results, particularly on the company's pipeline and market position. Some are speculating about potential M&A activity, while others focus on the potential for a significant price increase based on positive data and the company's overall value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Medical Stocks Lagging  Acurx Pharmaceuticals (ACXP) This Year?

Waters Q1 Earnings Surpass Estimates, Revenue Rise Y/Y

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI Acurx Announces Publication of Positive...

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors PR Newswire STATEN ISLAND...

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Acurx Pharmaceuticals, Inc. Announces Closing of $2.5 Million...

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering...

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)

Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI) Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3...

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications

Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based on Recent FDA and EMA Communications Acurx Updates Phase 3 Readiness for Ibezapolstat in C. difficile Infection Based...

Bitcoin Briefly Eclipses $99K Why Investors Just Can't Get Enough

Thomas Trutschel / Contributor / Getty ImagesKey TakeawaysBitcoin rose above $98,000 for the first time on Thursday.This marks a 46% increase since Donald Trump was announced as the winner of the...

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset

Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset PR Newswire STATEN ISLAND, N.Y., Nov. 20, 2024 STATEN ISLAND...

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Its research and development pipeline includes early-stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is headquartered in New York, NY.

Acurx Pharmaceuticals Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$4.60
Prev Close	$4.56
Open	$4.60
Dividend Yield	0.00%
50-Day Moving Average	$4.92
Beta	0.69
Avg. Volume	85,807.10
PE Ratio	-0.42

52-Week High	$44.00
52-Week Low	$3.80
Market Capitalization	$7.23M
EPS (Annual)	-$17.45
Price to Book	1.88
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ACXP
Acurx Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACXP News

ACXP Acurx Pharmaceuticals Inc